Find uplifting stories about heroes, innovations, and solutions
1634 results for "** chronic fatigue syndrome"
Australian researchers have discovered a genetic fault that could unlock the first diagnostic test and approved treatment for chronic fatigue syndrome, offering hope to 250,000 Australians. The breakthrough could transform life for patients who have spent decades without answers.
Australian researchers have discovered a physical cause for chronic fatigue syndrome: a broken waste-clearing system in the brain. The breakthrough could finally bring accurate diagnosis and treatment to millions of patients worldwide.
A small clinical trial reveals that ketamine, already used for depression, may offer rapid energy relief to millions suffering from chronic fatigue. The findings give hope to patients who've exhausted all other options.
A Buddhist meditation teacher who developed chronic illness from black mold exposure discovered how mindfulness and hypnosis can rewire the brain to help people suffering from ongoing health conditions. Her personal journey is now helping others find hope and healing.
After battling Stiff Person Syndrome for over two years, Celine Dion announced she's returning to perform in Paris this September. The beloved singer says she's managing her health and feeling good enough to reclaim the stage.
Scientists discovered a brain circuit that drives chronic pain separately from protective acute pain, opening the door to treatments that could help 60 million Americans without dulling their danger responses. When researchers silenced this circuit in mice, chronic pain disappeared while normal pain signals stayed intact.
For 50 million Americans living with chronic pain that drugs can't touch, Virginia Tech researchers just delivered groundbreaking news: they've reversed persistent pain in mice by targeting a previously overlooked biological pathway. The discovery could lead to the first new non-opioid chronic pain treatment in years.
Twenty-three years ago, Michelle Sie Whitten was told her daughter with Down syndrome would likely die young. Today, Sophia is thriving, and her mom is fighting to give families accurate information about the diagnosis.
Researchers at Harvard Medical School have developed a breakthrough gene-editing method that successfully silences the extra chromosome causing Down syndrome in up to 40% of lab cells. While still early stage, this proof-of-concept study opens the door to the first genuine treatment for one of the most common genetic conditions.
Breezy White just became the first person with Down syndrome to graduate from Georgia Highlands College and earn a college degree in Georgia. Her journey from childhood dream to 4.0 GPA student shows what's possible when opportunity meets determination.
A century after his birth, scientist Jérôme Lejeune's breakthrough discovery of Down syndrome's cause now powers a global network helping over 13,000 patients. The foundation bearing his name has become one of the world's leading research centers for genetic intellectual disabilities.
People with long Covid, POTS, and other chronic conditions are using fitness trackers to avoid debilitating crashes and reclaim their lives. After three years of tracking her health data, one journalist went from bedridden episodes to living crash-free.
A middle schooler designed a onesie for infants with Down syndrome after watching her brother struggle with regular clothes. Her invention won top prize at Coweta County's Innovation Expo, where 60+ student teams pitched products to solve real problems.
After two years of unexplained symptoms, Ashley Lucero discovered ultra-processed foods were sabotaging her health. Her simple ingredient swap transformed her energy and life in just four months.
Families affected by Hunter syndrome now have hope as the FDA approves Avlayah, the first treatment designed to replace a missing enzyme that causes dangerous sugar buildup in the brain. This breakthrough marks a major victory for patients with this rare genetic disease.
Researchers discovered that different mutations in Rett syndrome require different treatments, opening the door to personalized medicine for children with this developmental disorder. Using advanced brain tissue models, they successfully tested mutation-specific therapies that could help thousands of patients.
Virginia Tech researchers have successfully reversed chronic pain in mice by blocking a single enzyme pathway, offering hope for 50 million Americans whose pain doesn't respond to current treatments. The breakthrough targets a biological mechanism previously overlooked by conventional painkillers.
Researchers have identified the genetic fingerprint of "sleeping" pain neurons that affect 10% of people with chronic nerve pain. This breakthrough opens the door to targeted treatments that could silence overactive pain signals without affecting normal sensation.
The FDA just approved Denali Therapeutics' new medicine for Hunter syndrome, bringing fresh hope to families affected by this rare genetic disease. The approval comes as a welcome surprise after the agency recently toughened its standards for rare disease treatments.
A groundbreaking treatment could help children with Dravet syndrome not just reduce seizures, but actually improve cognitive development and daily living skills. For the first time, families facing this devastating genetic condition have hope for a disease-modifying therapy.
Showing 20 of 1634